Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nivya James

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Applied Biochemistry and Biotechnology|March 7, 2018
Ligand-Based Pharmacophore Screening Strategy: a Pragmatic Approach for Targeting HER ProteinsNivya James, K Ramanathan
Cell Biochemistry and Biophysics|May 7, 2017
Discovery of Potent ALK Inhibitors Using Pharmacophore-Informatics StrategyNivya James, K Ramanathan
Applied Biochemistry and Biotechnology|November 15, 2017
Drug Design for ALK-Positive NSCLC: an Integrated Pharmacophore-Based 3D QSAR and Virtual Screening StrategyNivya James, V Shanthi, K Ramanathan
Applied Biochemistry and Biotechnology|November 13, 2019
Density Functional Theory and Molecular Simulation Studies for Prioritizing Anaplastic Lymphoma Kinase InhibitorsNivya James, V Shanthi, K Ramanathan
Biotechnology and Applied Biochemistry|April 2, 2021
Discovery of potent Covid-19 main protease inhibitors using integrated drug-repurposing strategyMuthu Kumar T, Rohini K, Nivya James, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 15, 2018
Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug RepurposingPreethi Balasundaram, Rohini Kanagavelu, Nivya James, et al.
Biotechnology and Applied Biochemistry|September 24, 2020
Discovery of anaplastic lymphoma kinase inhibitors from natural product library: A holistic in silico approachSaranyadevi Subburaj, Tanvi Anand Nagrale, Mohd Mustufa Khan, et al.
Frontiers in Pharmacology|January 26, 2024
Optimizing drug discovery for snakebite envenoming via a high-throughput phospholipase A2 screening platformLaura-Oana Albulescu, Adam Westhorpe, Rachel H Clare, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Applied Biochemistry and Biotechnology|March 7, 2018
Ligand-Based Pharmacophore Screening Strategy: a Pragmatic Approach for Targeting HER ProteinsNivya James, K Ramanathan
Cell Biochemistry and Biophysics|May 7, 2017
Discovery of Potent ALK Inhibitors Using Pharmacophore-Informatics StrategyNivya James, K Ramanathan
Applied Biochemistry and Biotechnology|November 15, 2017
Drug Design for ALK-Positive NSCLC: an Integrated Pharmacophore-Based 3D QSAR and Virtual Screening StrategyNivya James, V Shanthi, K Ramanathan
Applied Biochemistry and Biotechnology|November 13, 2019
Density Functional Theory and Molecular Simulation Studies for Prioritizing Anaplastic Lymphoma Kinase InhibitorsNivya James, V Shanthi, K Ramanathan
Biotechnology and Applied Biochemistry|April 2, 2021
Discovery of potent Covid-19 main protease inhibitors using integrated drug-repurposing strategyMuthu Kumar T, Rohini K, Nivya James, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 15, 2018
Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug RepurposingPreethi Balasundaram, Rohini Kanagavelu, Nivya James, et al.
Biotechnology and Applied Biochemistry|September 24, 2020
Discovery of anaplastic lymphoma kinase inhibitors from natural product library: A holistic in silico approachSaranyadevi Subburaj, Tanvi Anand Nagrale, Mohd Mustufa Khan, et al.
Frontiers in Pharmacology|January 26, 2024
Optimizing drug discovery for snakebite envenoming via a high-throughput phospholipase A2 screening platformLaura-Oana Albulescu, Adam Westhorpe, Rachel H Clare, et al.
Pageof 1